 |
Analyze a Pharmaceutical Company: Corporate Strategy, Statements, Drugs in the Pipeline, Product Portfolios and Financial Data?
TOPIC: IMS Company Profiles (File 449, 984) examines annually the internal make-up of nearly 100 key pharmaceutical companies worldwide. Each individual profile analyzes the critical components that affect a company's business strategy, giving a clear assessment of a company's relative strengths and weaknesses. Companies profiled include public and private, producing ethical, biotech, or generic pharmaceuticals. File 449 is publicly available; File 984 is available only to subscribers of electronic or equivalent products from IMS. The record structure is identical between the two files.
In this example you will research Pfizer and TYPE out a record of its R&D pipeline.
COMMAND SUMMARY
BEGIN 449
VISUAL EXPAND CO=PFIZER
Check appropriate entries and click Select
In the Set Links pane, click S1 > Tasks > Rank
Check Section Name in the Rank menu and click OK
Check the section headings that are of interest to you and click Search
SELECT S2 AND PY=2008
SELECT S1 and S3
TYPE S4/6/ALL
Click Links > Display > Type Full Record (Record 12)
HOW TO...
1. BEGIN File 449 to search IMS Company Profiles for a company.
2. VISUAL EXPAND the company name using the Company Name (CO=) field. Use standard punctuation, spacing and word order.
3. Check the box before Pfizer and click Select.
|
|
4. In the Set Links pane, click S1 > Tasks > Rank.
|
|
5. Check the pop-up box in front of Section Name (SE) and click OK.
|
|
6. Check the Section headings that are of interest to you and click the Search button.
|
|
Notice that all the pages of the sections selected are now in S2.
|
 |
7. Combine Set 2 (S2) and the current year to retrieve the most latest data.
8. Combine the Pfizer set (S1) with the latest sections (S3).
Note: These could all be done in one search (e.g., SELECT S1 and S2 AND py=2008).
9. TYPE S4 in Format 6 to see the titles of each section.
Note: A number of records are omitted from this display. |
 |
| 10. Click Links at the top of the record you want to view > Display > Type Full Record. |
 |
Record 12 contains a listing of the R&D Pipeline for Pfizer. The table includes drugs in all phases of development.
The code refers to the code letters used for experimental substances. An explanation of the code prefixes is given in a table in the printed copy of the Merck Index and is a mnemonic of the company name.
For example, apixaban’s code (BMS 562247) indicates the substance was developed by Bristol-Myers Squibb and is the 562247th compound that was given a code within the company.
The class (B2C) refers to the therapeutic class code used by IMS Health. B2C indicates the drug is a proteinase inhibitor.
The Phase refers to the FDA Drug Development Phase (Phase I, Phase II, Phase III, Filed as an Investigational New Drug Application (IND), Approved).
Chemical searching techniques can be used to elucidate more data in other files about the individual drugs that are produced by the company of interest.
Note: A portion of this record is omitted from the display. |
 |
RELATED HOW DO I...? SOLUTIONS
NEED HELP?
Contact the Dialog Knowledge Center
Within North America +1 800 3 DIALOG (334 2564)
Outside North America 00 800 33 DIALOG (33 34 2564)
Web Form www.dialog.com/contacts/webform
|
You are viewing the
Click below to view the
 |
